Delivery Order SPE2DB22D1103-SPE2DB24FTLJ7
Award Date 5/29/24
Potential Completion Date 5/30/24
Potential Value $20K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,651.87 firm fixed-price delivery order is for the provision of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product used for various medical applications. The contract has an ultimate completion date of March 11, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,987.28 contract is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product used in the treatment of various medical conditions. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 31, 2024. Amerisourcebergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,468.23 firm fixed-price delivery order is for EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product, with a completion date of July 2, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,740.21, is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award, valued at $2,205.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product, with a performance period through May 6, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML. The contract has a ceiling value of $3,090.60 and is a firm fixed-price delivery order with a completion date of July 7, 2025. The contract is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,009.94, is for the delivery of EUFLEXXA 1% 20 MG/2 ML syringes. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) that runs through April 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999 IDC with the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a medical product, with a ceiling value of $16,319.54. The contract is a Delivery Order with a Firm Fixed Price pricing type, with a performance period ending on March 24, 2022. The award was made on March 23, 2022, and there was no set-aside designation...
- This is a $6,615.03 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a period of performance through February 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $29,725.52, is for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML medical products. The contract is a Firm Fixed Price Delivery Order with a completion date of February 12, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTLJ7Delivery Order
This federal contract award, valued at $20,157.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product, to support military healthcare programs globally. The award has an ultimate completion date of May 30, 2024 and utilizes a Firm Fixed Price pricing type. No set-aside designation was used for this contract.
Generated 5/16/25, 11:50 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.2k | 5/29/24 |